C.R. Bard to buy Medafor for $200M

• C.R. Bard (NYSE:BCR) will acquire Medafor for $200M up-front and $80M in revenue-based milestone payments over the next two years.
• The deal is expected to add 1% to FY14 revenue growth and will be "a few cents dilutive" to adjusted EPS this year. (PR)